Dr. Bailie: "Getting Back in the Game: Orthopedic Rehabilitation in the Athlete"

Dr. Bailie was asked to contribute and recently published 3 book chapters with co-author Todd Ellenbecker PT in "Getting Back in the Game: Orthopedic Rehabilitation in the Athlete" (Reider, Davies, Provencher, editors). The chapters are titled: Postoperative Rehab after Arthroscopic Rotator Cuff Repair (p 292-304), Post-Surgical Rehabilitation after Shoulder Arthroplasty (p 428-441), and Beyond Basic Rehabilitation: Return to Golf, Swimming and Tennis after Shoulder Replacement (p.441-448).

#RESULTS.RECOVERY.RELIEF. 

TOCA
602-277-6211
www.tocamd.com

TOCA is pleased to announce that Dr David S Bailie M.D. is a principal investigator of an investigational shoulder replacement device.

TOCA is pleased to announce that Dr David S Bailie M.D. is a principal investigator of an investigational shoulder replacement device.  The study is sponsored by Biomet Orthopedics (Warsaw IN), a major US manufacturer and distributor of orthopedic total joint implants and sports medicine devices.  The device, which was released in Europe last year, is being investigated at 12 centers in the US under an FDA-regulated study in order to compare the investigational device to the standard, currently available shoulder replacement.  The investigational device is currently not available for use outside of this study.  Dr. Bailie has been involved in this project for several years and has worked with Biomet on the technology, in collaboration with 3 other surgeons in the US and Canada.  He is proud to offer his patients, who are candidates for shoulder replacement, the opportunity to participate, should they meet the inclusion criteria set forth by the study protocol.  Dr. Bailie is the only surgeon west of Memphis, TN approved to use this device and participate in this study until the study is completed.  To learn more about this study and the risks associated therewith, and determine whether you may be a candidate, please call Dr. Bailie at The Orthopedic Clinic www.SportsMeddoc.com or by calling 602-277-6211.

TOCA

602-277-6211

www.tocamd.com

TOCA is pleased to announce that David S Bailie MD has been selected as a principal investigator of a new stemless total shoulder replacement device.

TOCA is pleased to announce that David S Bailie MD has been selected as a principal investigator of a new stemless total shoulder replacement device. This is a randomized study being conducted at 12 FDA approved medical facilities in the US. Dr. Bailie is the only orthopedic surgeon approved to use this device in the western US (west of  Memphis, TN). 

This FDA approved study is being sponsored by Biomet Orthopedics ( a worldwide manufacturer/distributor of Orthopedic devices, www.Biomet.com). 

Dr. Bailie has been selected by the FDA and the Western Institutional Review Board to participate and enroll qualified patients. The device has already been released and is currently being used in several European countries and the UK. Because the device is uniquely different than any current shoulder replacement on the market, in the US it requires a specifically designed FDA approved study, to be conducted by select surgeons, prior to general release to the remainder of the medical community. Until the study is complete (approximately 5-7 years), it will only be available as part of this study. Dr. Bailie is very excited to have been asked to participate in this "cutting-edge" research and be able to offer his patients a unique opportunity to participate. Participating orthopedic surgeons is by invitation only.

As criteria for patients to be included in this study is very specific and narrow, only those potential patients who are seen and examined personally by Dr. Bailie can be considered. This study will be performed under strict FDA and IRB monitoring until it is completed.



TOCA
602-277-6211
www.tocamd.com